Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 2Thoracic 2Head & Neck 1Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 66Lung Neoplasms 26Small Cell Lung Carcinoma 10Pancreatic Neoplasms 6Neoplasms 5Breast Neoplasms 5Stomach Neoplasms 4Squamous Cell Carcinoma of Head and Neck 4Parkinson Disease 4, Autosomal Dominant Lewy Body 4Neoplasm Metastasis 4Colorectal Neoplasms 4Carcinoma, Squamous Cell 4Urinary Bladder Neoplasms 3Triple Negative Breast Neoplasms 3Ovarian Neoplasms 3Carcinoma, Pancreatic Ductal 3Adenocarcinoma of Lung 3Sarcoma 2Recurrence 2Rectal Neoplasms 2Prostatic Neoplasms 2NSCLC 2Melanoma 2Lymphoma, Non-Hodgkin 2Head and Neck Neoplasms 2Esophageal Neoplasms 2Colonic Neoplasms 2Carcinoma, Transitional Cell 2Carcinoma 2Tumor Virus Infections 1

Interventions

Carboplatin 24Pemetrexed 18Cisplatin 17Paclitaxel 14pembrolizumab 13Gemcitabine 8osimertinib 7durvalumab 6Docetaxel 6Nivolumab 5Erlotinib Hydrochloride 5130-nm albumin-bound paclitaxel 5capmatinib 3brigatinib 3anlotinib 3Gefitinib 3Drug Therapy 3vosaroxin 2volociximab 2sintilimab 2pralsetinib 2ensartinib 2atezolizumab 2aflibercept 2Surgical Procedures, Operative 2Radiotherapy, Intensity-Modulated 2Radiotherapy 2Radiation 2Oncolytic Virotherapy 2Ipilimumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Carcinoma × Albumin-Bound Paclitaxel × Thoracic × Clear all
NCT02392507 2020-11-19

A Study of Nab-Paclitaxel and Carboplatin Plus Necitumumab (LY3012211) in Participants With Stage IV Squamous NSCLC

Eli Lilly and Company

Phase 2 Completed
54 enrolled 16 charts
Thoracic

Carcinoma, Carcinoma, Non-Small-Cell Lung

NCT02151149 2018-09-24

ABOUND 70+

Celgene

Phase 4 Completed
143 enrolled 25 charts
Thoracic

Adenocarcinoma, Carcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell, Lung Neoplasms, Carcinoma, Large Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡